Clinical Trials
4 trialsNCT06401330 2026-05-05
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Children's Oncology Group
Phase 3 Recruiting
NCT06882486 2026-03-20
NAMECAR
Institut Paoli-Calmettes
Phase NA Recruiting
NCT05738694 2026-03-17
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
Sun Yat-sen University
Phase 3 Recruiting
NCT05024318 2024-05-16
NAPSTER
Peter MacCallum Cancer Centre, Australia
Phase 2 Recruiting